Copyright Reports & Markets. All rights reserved.

Global Urine Based Glucose Monitoring Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Urine Based Glucose Monitoring Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Urine Based Glucose Monitoring Market Size Growth Rate by Product
      • 1.4.2 Wearable Blood Glucose Monitoring Systems
      • 1.4.3 Table Top Blood Glucose Monitoring Systems
    • 1.5 Market by End User
      • 1.5.1 Global Urine Based Glucose Monitoring Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Urine Based Glucose Monitoring Market Size
      • 2.1.1 Global Urine Based Glucose Monitoring Revenue 2014-2025
      • 2.1.2 Global Urine Based Glucose Monitoring Sales 2014-2025
    • 2.2 Urine Based Glucose Monitoring Growth Rate by Regions
      • 2.2.1 Global Urine Based Glucose Monitoring Sales by Regions
      • 2.2.2 Global Urine Based Glucose Monitoring Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Urine Based Glucose Monitoring Sales by Manufacturers
      • 3.1.1 Urine Based Glucose Monitoring Sales by Manufacturers
      • 3.1.2 Urine Based Glucose Monitoring Sales Market Share by Manufacturers
      • 3.1.3 Global Urine Based Glucose Monitoring Market Concentration Ratio (CR5 and HHI)
    • 3.2 Urine Based Glucose Monitoring Revenue by Manufacturers
      • 3.2.1 Urine Based Glucose Monitoring Revenue by Manufacturers (2014-2019)
      • 3.2.2 Urine Based Glucose Monitoring Revenue Share by Manufacturers (2014-2019)
    • 3.3 Urine Based Glucose Monitoring Price by Manufacturers
    • 3.4 Urine Based Glucose Monitoring Manufacturing Base Distribution, Product Types
      • 3.4.1 Urine Based Glucose Monitoring Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Urine Based Glucose Monitoring Product Type
      • 3.4.3 Date of International Manufacturers Enter into Urine Based Glucose Monitoring Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Urine Based Glucose Monitoring Sales by Product
    • 4.2 Global Urine Based Glucose Monitoring Revenue by Product
    • 4.3 Urine Based Glucose Monitoring Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Urine Based Glucose Monitoring Breakdown Data by End User

    6 North America

    • 6.1 North America Urine Based Glucose Monitoring by Countries
      • 6.1.1 North America Urine Based Glucose Monitoring Sales by Countries
      • 6.1.2 North America Urine Based Glucose Monitoring Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Urine Based Glucose Monitoring by Product
    • 6.3 North America Urine Based Glucose Monitoring by End User

    7 Europe

    • 7.1 Europe Urine Based Glucose Monitoring by Countries
      • 7.1.1 Europe Urine Based Glucose Monitoring Sales by Countries
      • 7.1.2 Europe Urine Based Glucose Monitoring Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Urine Based Glucose Monitoring by Product
    • 7.3 Europe Urine Based Glucose Monitoring by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Urine Based Glucose Monitoring by Countries
      • 8.1.1 Asia Pacific Urine Based Glucose Monitoring Sales by Countries
      • 8.1.2 Asia Pacific Urine Based Glucose Monitoring Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Urine Based Glucose Monitoring by Product
    • 8.3 Asia Pacific Urine Based Glucose Monitoring by End User

    9 Central & South America

    • 9.1 Central & South America Urine Based Glucose Monitoring by Countries
      • 9.1.1 Central & South America Urine Based Glucose Monitoring Sales by Countries
      • 9.1.2 Central & South America Urine Based Glucose Monitoring Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Urine Based Glucose Monitoring by Product
    • 9.3 Central & South America Urine Based Glucose Monitoring by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Urine Based Glucose Monitoring by Countries
      • 10.1.1 Middle East and Africa Urine Based Glucose Monitoring Sales by Countries
      • 10.1.2 Middle East and Africa Urine Based Glucose Monitoring Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Urine Based Glucose Monitoring by Product
    • 10.3 Middle East and Africa Urine Based Glucose Monitoring by End User

    11 Company Profiles

    • 11.1 Abbott
      • 11.1.1 Abbott Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Urine Based Glucose Monitoring Products Offered
      • 11.1.5 Abbott Recent Development
    • 11.2 Medtronic
      • 11.2.1 Medtronic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic Urine Based Glucose Monitoring Products Offered
      • 11.2.5 Medtronic Recent Development
    • 11.3 Roche
      • 11.3.1 Roche Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Roche Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Roche Urine Based Glucose Monitoring Products Offered
      • 11.3.5 Roche Recent Development
    • 11.4 Bayer AG
      • 11.4.1 Bayer AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Bayer AG Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Bayer AG Urine Based Glucose Monitoring Products Offered
      • 11.4.5 Bayer AG Recent Development
    • 11.5 B. Braun
      • 11.5.1 B. Braun Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 B. Braun Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 B. Braun Urine Based Glucose Monitoring Products Offered
      • 11.5.5 B. Braun Recent Development
    • 11.6 Nipro Diagnostics
      • 11.6.1 Nipro Diagnostics Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Nipro Diagnostics Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Nipro Diagnostics Urine Based Glucose Monitoring Products Offered
      • 11.6.5 Nipro Diagnostics Recent Development
    • 11.7 Life Scan Inc.(J&J)
      • 11.7.1 Life Scan Inc.(J&J) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Products Offered
      • 11.7.5 Life Scan Inc.(J&J) Recent Development
    • 11.8 Arkray Devices
      • 11.8.1 Arkray Devices Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Arkray Devices Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Arkray Devices Urine Based Glucose Monitoring Products Offered
      • 11.8.5 Arkray Devices Recent Development
    • 11.9 Nova Biomedical
      • 11.9.1 Nova Biomedical Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Nova Biomedical Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Nova Biomedical Urine Based Glucose Monitoring Products Offered
      • 11.9.5 Nova Biomedical Recent Development
    • 11.10 Bionime Corporation
      • 11.10.1 Bionime Corporation Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Bionime Corporation Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Bionime Corporation Urine Based Glucose Monitoring Products Offered
      • 11.10.5 Bionime Corporation Recent Development

    12 Future Forecast

    • 12.1 Urine Based Glucose Monitoring Market Forecast by Regions
      • 12.1.1 Global Urine Based Glucose Monitoring Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Urine Based Glucose Monitoring Revenue Forecast by Regions 2019-2025
    • 12.2 Urine Based Glucose Monitoring Market Forecast by Product
      • 12.2.1 Global Urine Based Glucose Monitoring Sales Forecast by Product 2019-2025
      • 12.2.2 Global Urine Based Glucose Monitoring Revenue Forecast by Product 2019-2025
    • 12.3 Urine Based Glucose Monitoring Market Forecast by End User
    • 12.4 North America Urine Based Glucose Monitoring Forecast
    • 12.5 Europe Urine Based Glucose Monitoring Forecast
    • 12.6 Asia Pacific Urine Based Glucose Monitoring Forecast
    • 12.7 Central & South America Urine Based Glucose Monitoring Forecast
    • 12.8 Middle East and Africa Urine Based Glucose Monitoring Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Urine Based Glucose Monitoring Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Urine Based Glucose Monitoring market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Urine Based Glucose Monitoring market based on company, product type, end user and key regions.

      This report studies the global market size of Urine Based Glucose Monitoring in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Urine Based Glucose Monitoring in these regions.
      This research report categorizes the global Urine Based Glucose Monitoring market by top players/brands, region, type and end user. This report also studies the global Urine Based Glucose Monitoring market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Abbott
      Medtronic
      Roche
      Bayer AG
      B. Braun
      Nipro Diagnostics
      Life Scan Inc.(J&J)
      Arkray Devices
      Nova Biomedical
      Bionime Corporation

      Market size by Product
      Wearable Blood Glucose Monitoring Systems
      Table Top Blood Glucose Monitoring Systems
      Market size by End User
      Hospitals
      Clinics
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Urine Based Glucose Monitoring market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Urine Based Glucose Monitoring market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Urine Based Glucose Monitoring companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Urine Based Glucose Monitoring submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Urine Based Glucose Monitoring are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Urine Based Glucose Monitoring market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now